NEW YORK--(BUSINESS WIRE)--June 5, 2006--Amphion Innovations plc (LSE:AMP - News; “Amphion”), a leading developer and operator of companies in the life sciences and medical technology sectors, today announced that its partner company, Motif BioSciences, Inc., played an instrumental role in the design and development of The Shafallah Center’s Genetics Medical Center (SGMC) at the Shafallah Center for Children with Special Needs, which opened last month in Doha, Qatar.
